Local Chinese Companies With Mix Of TCM And Western Medicines Poised For Strong Growth
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Tongitang Chinese Medicines Company, a developer and manufacturer of modernized traditional Chinese medicines is streamlining its operations by getting rid of less profitable segments and expanding its pipeline
You may also be interested in...
Traditional Chinese Medicines Seen As Global Growth Opportunity
HONG KONG - Health authorities around the world are working to develop regulatory structures for traditional Chinese medicines
Traditional Chinese Medicines Seen As Global Growth Opportunity
HONG KONG - Health authorities around the world are working to develop regulatory structures for traditional Chinese medicines
Tongjitang Pins Loss On Delayed Implementation Of China's Essential Drug List; Proposed Buyout Still Under Review
SHANGHAI - Tongjitang, the first traditional Chinese medicine company listed on the New York Stock Exchange, reported a $694,000 net loss during the second quarter for the year, attributing it to increased sales and marketing expenses for sales infrastructure and its essential drug sales network